Immunovia completes analytical validation of its next-generation pancreatic cancer test ...Middle East

PR Newswire - News
LUND, Sweden, Oct. 2, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announces that the company has completed the analytical validation of its next-generation test designed to detect early-stage pancreatic cancer. The validation...

Hence then, the article about immunovia completes analytical validation of its next generation pancreatic cancer test was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunovia completes analytical validation of its next-generation pancreatic cancer test )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News